Designing circulating tumor DNA-based interventional clinical trials in oncology

Editorial summaryCirculating tumor (ct) DNA is a powerful tool that can be used to track cancer beyond a single snapshot in space and time. It has potential applications in detecting minimal residual disease and predicting relapse, in selecting patients for tailored treatments, and in revealing mechanisms of response or resistance. Here, we discuss the incorporation of ctDNA into clinical trials.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research